Characteristics | Values |
---|---|
Male, n(%) | 20 ( 64.5) |
Age at FAPI scan, mean ± SD, years | 58.2 ± 8.5 |
Jaundice, n(%) | 12 ( 38.7) |
Clinical indication for PET/CT | |
Clarifying the nature of the lesion, n(%) | 20 ( 64.5) |
Initial staging, n(%) | 9 ( 29.0) |
Restaging, n(%) | 2 ( 6.5) |
Blood Results | |
Median (25th-75th percentile range) CA19-9a, U/ml | 89.2 ( 35.9–144.8) |
Median (25th-75th percentile range) Serum Amylase, U/l | 60.7 ( 33.8–83.8) |
Location of the primary lesion, n(%) | |
Head | 16 ( 51.6) |
Body | 10 ( 32.3) |
Tail | 5 ( 16.1) |
Cholangiectasis observed by Al18F-NOTA-FAPI-04 PET/CT, n(%) | 14 ( 45.1) |
Expansion of the pancreatic duct | 22 ( 71.0) |